Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07KON
|
|||
| Drug Name |
PMID30273516-Compound-22b
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ASTRAZENECA AB CANCER RESEARCH TECHNOLOGY LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutaminase (GLS) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Glutaminase (GLS) | Target's Patent Info | [1] | |
| KEGG Pathway | Arginine biosynthesis | |||
| Alanine, aspartate and glutamate metabolism | ||||
| D-Glutamine and D-glutamate metabolism | ||||
| Metabolic pathways | ||||
| Glutamatergic synapse | ||||
| GABAergic synapse | ||||
| Proximal tubule bicarbonate reclamation | ||||
| MicroRNAs in cancer | ||||
| Central carbon metabolism in cancer | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Glutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2018 Nov;28(11):823-835. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.